Author:
Onodera Atsushi,Kokubo Kota,Okano Mikiko,Onoue Miki,Kiuchi Masahiro,Iwamura Chiaki,Iinuma Tomohisa,Kimura Motoko Y.,Ebihara Nobuyuki,Hanazawa Toyoyuki,Nakayama Toshinori,Hirahara Kiyoshi
Funder
MSD Life Science Foundation, Public Interest Incorporated Foundation
Japan Agency for Medical Research and Development
Ministry of Education, Culture, Sports, Science and Technology
Japan Science and Technology Agency
Kowa Life Science Foundation
Astellas Foundation for Research on Metabolic Disorders
Subject
Pharmacology (medical),Pharmacology
Reference105 articles.
1. Therapeutic targeting of the Jak/STAT pathway;Aittomaki;Basic & Clinical Pharmacology & Toxicology,2014
2. Diversity and dialogue in immunity to helminths;Allen;Nature Reviews. Immunology,2011
3. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling;Amano;The Journal of Allergy and Clinical Immunology,2015
4. mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection;Ando;The Journal of Clinical Investigation,2023
5. Eosinophils: Cells known for over 140 years with broad and new functions;Aoki;Allergology International,2021